AAA to hear biotech claim against Japanese drugmaker

A US biotech company has filed a claim with the American Arbitration Association against Daiichi Sankyo over the ownership of technology the Japanese group is using in a drug candidate to treat breast cancer.

Unlock unlimited access to all Global Arbitration Review content